Brief: Natco Pharma Received Establishment Inspection Report From The USFDA For Its Facility At Visakhapatnam, Andhra Pradesh
June 15 (Reuters) - Natco Pharma Ltd NATP.NS :
* RECEIVED ESTABLISHMENT INSPECTION REPORT FROM THE USFDA
FOR ITS
FACILITY AT VISAKHAPATNAM, ANDHRA PRADESH
Source text for Eikon: ID:nBSE9BJ3Jq
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees